EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Evaluation of coadministration schedules of rA1M for kidney protection after administration of 177Lu-octreotide

Nishte Rassol iD, Charlotte Ytterbrink, Daniella Pettersson, Amin Al-Awar, Hana Bakr, Magnus Gram iD, Johan Spetz, Eva Forssell-Aronsson iD

Radiation Protection Dosimetry · 2025

DOI: 10.1093/rpd/ncaf090 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Radiation Protection Dosimetry, 2025. Verfasst von Nishte Rassol und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Radiation Sciences, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, SE-413 45 Gothenburg, Sweden. Hauptthemen laut MEDLINE: Octreotide, Kidney, Radiopharmaceuticals, Radiation Injuries. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: ALF-agreement, Swedish Cancer Society, Swedish Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Late radiation-induced kidney toxicity limits molecular radionuclide therapy using radiopharmaceuticals such as 177Lu-octreotate and 177Lu-octreotide. Better kidney protection would allow higher amounts of radiopharmaceutical to be administered. Coadministration of recombinant human alpha-1-microglobulin (rA1M) has been suggested to protect kidneys from exposure from 177Lu-octreotate. Furthermore, early responding biomarkers are needed that identify patients that should or should not receive higher radiopharmaceutical activity. The aim of this study was to evaluate effects of different administration schedules of rA1M in combination with 177Lu-octreotide on urinary levels of retinol-binding protein 4 (RBP4) and creatinine (Cr). Mice received 60 MBq 177Lu-octreotide intravenously, plus none, one, or several rA1M injections. Urinary RBP4 and Cr concentrations were measured after 6–10 weeks. Urinary RBP4 was similar in all groups, but with large individual variations in some groups. RBP4/Cr may be a useful early-responding biomarker. Further investigations are needed to determine effects of long-term kidney protection by rA1M schedules.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OctreotideKidneyRadiopharmaceuticalsRadiation InjuriesRadiation-Protective AgentsKidney DiseasesAnimalsMiceHumansRecombinant ProteinsMaleBiomarkersDrug Administration ScheduleCreatinineRadioisotopesFemaleAlpha-Globulins

Substanzen

OctreotideRadiopharmaceuticalsalpha-1-microglobulinRecombinant ProteinsRadiation-Protective AgentsBiomarkersCreatinineRadioisotopesAlpha-Globulins

Autor:innen und Institutionen

  • Department of Medical Radiation Sciences, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, SE-413 45 Gothenburg, Sweden.
  • Sahlgrenska Centre for Cancer Research, Sahlgrenska Academy, University of Gothenburg, Box 425, SE-405 30 Gothenburg, Sweden.
  • Medical Physics and Biomedical Engineering, Sahlgrenska University Hospital, SE-413 45 Gothenburg, Sweden.
  • Paediatrics, Department of Clinical Sciences Lund, Lund University, SE-221 85 Lund, and Department of Neonatology, Skåne University Hospital, SE-221 84 Lund, Sweden.
  • Biofilms-Research Centre for Biointerfaces, Department of Biomedical Science, Faculty of Health and Society, Malmö University, SE-205 06 Malmö, Sweden.

ORCID-Profile: Nishte Rassol, Magnus Gram, Eva Forssell-Aronsson

Förderung

  • ALF-agreement
  • Swedish Cancer Society
  • Swedish Research Council

Zitieren

APA

Rassol, N., Ytterbrink, C., Pettersson, D., Al-Awar, A., Bakr, H., Gram, M., Spetz, J., & Forssell-Aronsson, E. (2025). Evaluation of coadministration schedules of rA1M for kidney protection after administration of 177Lu-octreotide. Radiation Protection Dosimetry. https://doi.org/10.1093/rpd/ncaf090

Vancouver

Rassol N, Ytterbrink C, Pettersson D, Al-Awar A, Bakr H, Gram M, et al. Evaluation of coadministration schedules of rA1M for kidney protection after administration of 177Lu-octreotide. Radiation Protection Dosimetry. 2025. doi:10.1093/rpd/ncaf090

BibTeX
@article{Rassol2025,
  author = {Rassol, Nishte and Ytterbrink, Charlotte and Pettersson, Daniella and Al-Awar, Amin and Bakr, Hana and Gram, Magnus and Spetz, Johan and Forssell-Aronsson, Eva},
  title = {Evaluation of coadministration schedules of rA1M for kidney protection after administration of 177Lu-octreotide},
  journal = {Radiation Protection Dosimetry},
  year = {2025},
  doi = {10.1093/rpd/ncaf090}
}
Kostenlos starten →